APA (7th ed.) Citation

CG, C., S, L. F., S, I., G, S., F, R., S, R., . . . F, P. (2025). Real-world effectiveness and safety of ofatumumab in relapsing-remitting multiple sclerosis: Insights from naïve and switch patients. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 22(6), e00724. https://doi.org/10.1016/j.neurot.2025.e00724

Chicago Style (17th ed.) Citation

CG, Chisari, et al. "Real-world Effectiveness and Safety of Ofatumumab in Relapsing-remitting Multiple Sclerosis: Insights from Naïve and Switch Patients." Neurotherapeutics : The Journal of the American Society for Experimental NeuroTherapeutics 22, no. 6 (2025): e00724. https://doi.org/10.1016/j.neurot.2025.e00724.

MLA (9th ed.) Citation

CG, Chisari, et al. "Real-world Effectiveness and Safety of Ofatumumab in Relapsing-remitting Multiple Sclerosis: Insights from Naïve and Switch Patients." Neurotherapeutics : The Journal of the American Society for Experimental NeuroTherapeutics, vol. 22, no. 6, 2025, p. e00724, https://doi.org/10.1016/j.neurot.2025.e00724.